nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentagastrin—CCKBR—Peptide GPCRs—GNRHR—adrenal gland cancer	0.115	0.135	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Other—GNRHR—adrenal gland cancer	0.0973	0.115	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide GPCRs—TSHR—adrenal gland cancer	0.0613	0.0722	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0547	0.0645	CbGpPWpGaD
Pentagastrin—Nafarelin—GNRHR—adrenal gland cancer	0.054	0.357	CrCbGaD
Pentagastrin—Gonadorelin—GNRHR—adrenal gland cancer	0.0515	0.34	CrCbGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0489	0.0576	CbGpPWpGaD
Pentagastrin—Goserelin—GNRHR—adrenal gland cancer	0.0431	0.285	CrCbGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0362	0.0427	CbGpPWpGaD
Pentagastrin—CCKBR—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0328	0.0386	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.0293	0.0345	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0276	0.0325	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0217	0.0256	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0193	0.0228	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0165	0.0195	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0156	0.0184	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—TSHR—adrenal gland cancer	0.0147	0.0174	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0142	0.0167	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—REN—adrenal gland cancer	0.0136	0.016	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.0113	0.0133	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0109	0.0129	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00934	0.011	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—GNAS—adrenal gland cancer	0.00857	0.0101	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00848	0.00999	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—KCNJ5—adrenal gland cancer	0.00837	0.00987	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GNRHR—adrenal gland cancer	0.00836	0.00985	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00832	0.00981	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00778	0.00916	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00758	0.00893	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—TSHR—adrenal gland cancer	0.00756	0.00891	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00731	0.00861	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00579	0.00682	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—POMC—adrenal gland cancer	0.00577	0.0068	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00543	0.00639	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00507	0.00597	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GNRH1—adrenal gland cancer	0.00501	0.0059	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00484	0.00571	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—CDC42—adrenal gland cancer	0.0046	0.00542	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—SPRY2—adrenal gland cancer	0.00458	0.0054	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—POMC—adrenal gland cancer	0.00453	0.00534	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—TSHR—adrenal gland cancer	0.00447	0.00526	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—GNAS—adrenal gland cancer	0.0044	0.00518	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—MEN1—adrenal gland cancer	0.0042	0.00495	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00419	0.00493	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—POMC—adrenal gland cancer	0.00326	0.00384	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—CTNNB1—adrenal gland cancer	0.00323	0.00381	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—PRKACA—adrenal gland cancer	0.00321	0.00378	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PRKACA—adrenal gland cancer	0.00321	0.00378	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—POMC—adrenal gland cancer	0.00296	0.00349	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—CDC42—adrenal gland cancer	0.00272	0.0032	CbGpPWpGaD
Pentagastrin—Carfilzomib—ABCB1—adrenal gland cancer	0.0027	0.0179	CrCbGaD
Pentagastrin—CCKBR—Signaling Pathways—IGF2—adrenal gland cancer	0.00262	0.00309	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GNAS—adrenal gland cancer	0.0026	0.00306	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—REN—adrenal gland cancer	0.00257	0.00303	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IGF1R—adrenal gland cancer	0.00253	0.00298	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00249	0.00293	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—SDHB—adrenal gland cancer	0.00231	0.00272	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00226	0.00266	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—TERT—adrenal gland cancer	0.00218	0.00257	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—BAD—adrenal gland cancer	0.0019	0.00224	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00181	0.00214	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—POMC—adrenal gland cancer	0.00175	0.00206	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—BRAF—adrenal gland cancer	0.00173	0.00204	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—BRAF—adrenal gland cancer	0.00173	0.00203	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—EGFR—adrenal gland cancer	0.00167	0.00197	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—SDHD—adrenal gland cancer	0.00149	0.00175	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—RRM1—adrenal gland cancer	0.00149	0.00175	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—IGF2—adrenal gland cancer	0.00128	0.00151	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00125	0.00147	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—MED12—adrenal gland cancer	0.00111	0.00131	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00099	0.00117	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—EGFR—adrenal gland cancer	0.000989	0.00117	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—POMC—adrenal gland cancer	0.000856	0.00101	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—TP53—adrenal gland cancer	0.00083	0.000978	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PRKACA—adrenal gland cancer	0.000808	0.000952	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00079	0.000931	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GNAS—adrenal gland cancer	0.000655	0.000772	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—ABCB1—adrenal gland cancer	0.000643	0.000757	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.000611	0.000719	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—POMC—adrenal gland cancer	0.000441	0.00052	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PTGS2—adrenal gland cancer	0.000352	0.000414	CbGpPWpGaD
